ArticleJournal for immunotherapy of cancer2021

GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer.

Jin-Li Wei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.